Could NPDR Be Treated Orally?

• March 24, 2026

FDA Clears Nocturnal IOP Device

Balance Ophthalmics gains FDA 510(k) clearance for wireless FSYX glaucoma device

• May 26, 2026

• 2 min

EYP-1901 for Retinal Exudative Diseases

Updates from the clinical trial program in Wet AMD and DME

• by Ashkan M. Abbey

• May 29, 2026

• 6 min

Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease

• by Zhengtai Sun, Yuting Liu, Lijuan Que

• May 28, 2026